CARRIER FOR DRUG DELIVERY AND CONJUGATE, COMPOSITION CONTAINING SAME, AND METHOD FOR ADMINISTERING SAME
申请人:The University of Tokyo
公开号:EP3072506A1
公开(公告)日:2016-09-28
The present invention provides a vesicle, a conjugate, a composition comprising the vesicle or the conjugate, for use in delivering a drug to the brain, and a method for administering the same. The composition of the present invention is a composition for administration to a subject according to a dosing regimen, comprising a carrier for drug delivery, wherein the dosing regimen comprises administering the composition to a subject who has been fasted or caused to have hypoglycemia and inducing an increase in blood glucose level in the subject, and the carrier is modified at the outer surface thereof with a GLUT1 ligand.
Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same
申请人:THE UNIVERSITY OF TOKYO
公开号:US10912838B2
公开(公告)日:2021-02-09
The present invention provides a vesicle, a conjugate, a composition comprising the vesicle or the conjugate, for use in delivering a drug to the brain, and a method for administering the same. The composition of the present invention is a composition for administration to a subject according to a dosing regimen, comprising a carrier for drug delivery, wherein the dosing regimen comprises administering the composition to a subject who has been fasted or caused to have hypoglycemia and inducing an increase in blood glucose level in the subject, and the carrier is modified at the outer surface thereof with a GLUT1 ligand.
CARRIER FOR USE IN DELIVERING DRUG, CONJUGATE, COMPOSITION COMPRISING SAME, AND METHOD FOR ADMINISTRATING SAME
申请人:THE UNIVERSITY OF TOKYO
公开号:US20160287714A1
公开(公告)日:2016-10-06
The present invention provides a vesicle, a conjugate, a composition comprising the vesicle or the conjugate, for use in delivering a drug to the brain, and a method for administering the same. The composition of the present invention is a composition for administration to a subject according to a dosing regimen, comprising a carrier for drug delivery, wherein the dosing regimen comprises administering the composition to a subject who has been fasted or caused to have hypoglycemia and inducing an increase in blood glucose level in the subject, and the carrier is modified at the outer surface thereof with a GLUT1 ligand.
US9937263B2
申请人:——
公开号:US9937263B2
公开(公告)日:2018-04-10
Ohle; Euler, Chemische Berichte, 1936, vol. 69, p. 1022,1024